[1] Saran R, Robinson B, Abbott K. United States Renal Data System: 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States [J]. American Journal of Kidney Diseases, 2017, 69(3): A4.
[2] Chatzimanouil M K T, Wilkens L, Anders H J. Quantity and Reporting Quality of Kidney Research [J]. J Am Soc Nephrol, 2019, 30(1): 13-22.
[3] Lok C E, Huber T S, Lee T, Shenoy S, Yevzlin A S, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update [J]. Am J Kidney Dis, 2020, 75(4 Suppl 2): S1-s164.
[4] 金其庄, 王玉柱, 叶朝阳, 施雅雪. 中国血液透析用血管通路专家共识(第2版) [J]. 中国血液净化, 2019, 18(06): 365-81.
[5] Viecelli A K, Mori T A, Roy-Chaudhury P, Polkinghorne K R, Hawley C M, Johnson D W, et al. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled [J]. Semin Dial, 2018, 31(3): 244-57.
[6] Riella M C, Roy-Chaudhury P. Vascular access in haemodialysis: strengthening the Achilles' heel [J]. Nat Rev Nephrol, 2013, 9(6): 348-57.
[7] Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access [J]. Nephrol Dial Transplant, 2009, 24(9): 2786-91.
[8] Cheung A K, Imrey P B, Alpers C E, Robbin M L, Radeva M, Larive B, et al. Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study [J]. J Am Soc Nephrol, 2017, 28(10): 3005-13.
[9] Allon M, Robbin M L. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions [J]. Kidney Int, 2002, 62(4): 1109-24.
[10] Roy-Chaudhury P, Kruska L. Future directions for vascular access for hemodialysis [J]. Semin Dial, 2015, 28(2): 107-13.
[11] Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO [J]. Arterioscler Thromb Vasc Biol, 2000, 20(12): E120-6.
[12] Lehoux S, Castier Y, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces [J]. J Intern Med, 2006, 259(4): 381-92.
[13] Roy-Chaudhury P, Sukhatme V P, Cheung A K. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint [J]. J Am Soc Nephrol, 2006, 17(4): 1112-27.
[14] Paszkowiak J J, Dardik A. Arterial wall shear stress: observations from the bench to the bedside [J]. Vasc Endovascular Surg, 2003, 37(1): 47-57.
[15] Smith G E, Gohil R, Chetter I C. Factors affecting the patency of arteriovenous fistulas for dialysis access [J]. J Vasc Surg, 2012, 55(3): 849-55.
[16] Miller C D, Robbin M L, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients [J]. J Am Soc Nephrol, 2003, 14(11): 2942-7.
[17] Miller P E, Carlton D, Deierhoi M H, Redden D T, Allon M. Natural history of arteriovenous grafts in hemodialysis patients [J]. Am J Kidney Dis, 2000, 36(1): 68-74.
[18] Wilson L, Miller H P, Farrell K W, Snyder K B, Thompson W C, Purich D L. Taxol stabilization of microtubules in vitro: dynamics of tubulin addition and loss at opposite microtubule ends [J]. Biochemistry, 1985, 24(19): 5254-62.
[19] Jordan M A, Toso R J, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations [J]. Proc Natl Acad Sci U S A, 1993, 90(20): 9552-6.
[20] Wessely R, Sch?mig A, Kastrati A. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different [J]. J Am Coll Cardiol, 2006, 47(4): 708-14.
[21] Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery [J]. J Vasc Surg, 2014, 59(4): 1123-33.e8.
[22] Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial [J]. J Endovasc Ther, 2012, 19(2): 263-72.
[23] Kitrou P M, Katsanos K, Spiliopoulos S, Karnabatidis D, Siablis D. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472) [J]. Eur J Radiol, 2015, 84(3): 418-23.
[24] Irani F G, Teo T K B, Tay K H, Yin W H, Win H H, Gogna A, et al. Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty [J]. Radiology, 2018, 289(1): 238-47.
[25] Liao M T, Lee C P, Lin T T, Jong C B, Chen T Y, Lin L, et al. A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts [J]. J Vasc Surg, 2020, 71(6): 1994-2003.
[26] Moreno-Sánchez T, Moreno-Ramírez M, Machancoses F H, Pardo-Moreno P, Navarro-Vergara P F, García-Revillo J. Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons: A Controlled, Multicenter, Randomized Trial [J]. Cardiovasc Intervent Radiol, 2020, 43(3): 382-90.
[27] Pang S Y C, Au-Yeung K C L, Liu G Y L, Tse R O H, Lai D, Leung W K W, et al. Randomized Controlled Trial for Paclitaxel-coated Balloon versus Plain Balloon Angioplasty in Dysfunctional Hemodialysis Vascular Access: 12-month Outcome from a Nonsponsored Trial [J]. Ann Vasc Surg, 2020,
[28] Lookstein R A, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, et al. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas [J]. N Engl J Med, 2020, 383(8): 733-42.
[29] Kitrou P M, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E, et al. Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial [J]. J Vasc Interv Radiol, 2017, 28(6): 811-7.
[30] Trerotola S O, Roy-Chaudhury P, Saad T F. Drug-Coated Balloons in Dysfunctional Arteriovenous Fistulas: Is it Time? [J]. Am J Kidney Dis, 2020,
[31] Yin Y, Shi Y, Cui T, Li H, Chen J, Zhang L, et al. Efficacy and safety of paclitaxel-coated balloon angioplasty for dysfunctional arteriovenous fistulas: a multicenter randomized controlled trial [J]. Am J Kidney Dis, 2021,
[32] Kim J W, Kim J H, Byun S S, Kang J M, Shin J H. Paclitaxel-Coated Balloon versus Plain Balloon Angioplasty for Dysfunctional Autogenous Radiocephalic Arteriovenous Fistulas: A Prospective Randomized Controlled Trial [J]. Korean J Radiol, 2020, 21(11): 1239-47.
[33] Trerotola S O, Saad T F, Roy-Chaudhury P. The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis [J]. J Vasc Interv Radiol, 2020, 31(1): 1-14.e5.
[34] Therasse E, Caty V, Gilbert P, Giroux M F, Perreault P, Bouchard L, et al. Safety and Efficacy of Paclitaxel-Eluting Balloon Angioplasty for Dysfunctional Hemodialysis Access: A randomized trial Comparing with Angioplasty Alone [J]. J Vasc Interv Radiol, 2021,
[35] Kitrou P M, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial [J]. J Vasc Interv Radiol, 2015, 26(3): 348-54.
[36] Swinnen J J, Hitos K, Kairaitis L, Gruenewald S, Larcos G, Farlow D, et al. Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses [J]. J Vasc Access, 2019, 20(3): 260-9.
[37] Bj?rkman P, Weselius E M, Alb?ck A, Venermo M. Drug-Coated Balloons vs. Balloon Angioplasty in AV-Fistulas: A Randomized, Controlled Study with 1-Year Follow-Up [J]. European Journal of Vascular and Endovascular Surgery, 2019, 58(6): e93-e4.
[38] Maleux G, Vander Mijnsbrugge W, Henroteaux D, Laenen A, Cornelissen S, Claes K, et al. Multicenter, Randomized Trial of Conventional Balloon Angioplasty versus Paclitaxel-Coated Balloon Angioplasty for the Treatment of Dysfunctioning Autologous Dialysis Fistulae [J]. J Vasc Interv Radiol, 2018, 29(4): 470-5.e3.
[39] Gray R J, Sacks D, Martin L G, Trerotola S O. Reporting standards for percutaneous interventions in dialysis access [J]. J Vasc Interv Radiol, 2003, 14(9 Pt 2): S433-42.
[40] Kitrou P, Spiliopoulos S, Papadimatos P, Lampropoulos G, Christeas N, Karnabatidis D. Paclitaxel-coated balloon versus plain balloon angioplasty for the treatment of symptomatic central venous stenosis in dialysis access. Six-month results from a prospective single-center randomized trial [J]. Journal of Vascular and Interventional Radiology, 2016, 27(3): S161-S2.
[41] 赵德龙. 维持性血液透析患者流行病学调查及生存预后相关性分析 [D]; 解放军总医院(北京301医院)&军医进修学院, 2016.
